From ANDA to Shelf: How Generic Drugs Reach Retail Pharmacies
Discover how generic drugs go from regulatory approval via ANDA to your pharmacy shelf - the steps, players, and delays that make affordable medicine possible.
Read MoreDiscover how generic drugs go from regulatory approval via ANDA to your pharmacy shelf - the steps, players, and delays that make affordable medicine possible.
Read MoreBioequivalence studies for generic drugs have long relied on young, healthy men. New regulations now require balanced representation of age and sex-here’s what that means for patients and the future of generic medications.
Read MoreAn ANDA is the FDA pathway that lets generic drug makers prove their products match brand-name drugs in safety and effectiveness - without repeating costly clinical trials. It’s why 90% of prescriptions are filled with generics that cost far less.
Read MoreLearn how coupons, generics, and prior authorizations impact your prescription costs in 2025. Discover practical ways to save money on medications and understand the new Medicare changes coming in 2026.
Read MoreLong-term care insurance doesn't cover generic drugs in nursing homes. Medicare Part D is the main payer, but formularies and coverage gaps leave many residents at risk. Learn how to protect yourself and your loved ones.
Read MoreThe global generic drug market is evolving fast, driven by biosimilars, supply chain shifts, and emerging economies. Discover key trends shaping affordability, manufacturing, and access to medicine by 2030.
Read MoreBiosimilars and generics both lower drug costs, but they're not the same. Learn how they differ in science, cost, and use-so you can make the right choice for your treatment.
Read More© 2026. All rights reserved.